You are using software which is blocking our advertisements (adblocker).
As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!
Click here for a guide on disabling your adblocker.
Sign up for our daily Newsletter and stay up to date with all the latest news!
You are receiving this pop-up because this is the first time you are visiting our site. If you keep getting this message, please enable cookies in your browser.
Verano has submitted applications with the U.S. Drug Enforcement Agency to register certain state-licensed medical cannabis operations, pursuant to the expedited registration pathway provided by the federal rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.
© Verano Holdings
“Submitting the DEA license applications marks a significant step forward for Verano on our path to becoming a federally legal business,” said George Archos, Verano founder, Chairman and Chief Executive Officer. “Verano has embraced a medical and patient-first ethos since day one, and with medical cannabis sales accounting for a majority of our retail business, we look forward to unlocking the full medical, research and commercial potential of cannabis under the new Schedule III designation.”
For more information:
Verano Holdings
[email protected]
verano.com
FreshPublishers © 2005-2026 MMJDaily.com